Understanding how immune cells can fight cancer
Characterization of anti-tumor networks in tumor-associated macrophages
This study is looking at how certain immune cells called tumor-associated macrophages can help fight cancer, with the hope of finding new ways to make cancer treatments work better for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Salk Institute for Biological Studies NIH-funded |
| Lab location | 1 site (La Jolla, UNITED STATES) |
| Project ID | NIH-11059242 on NIH RePORTER |
What this research studies
This research investigates the role of tumor-associated macrophages, a type of immune cell, in combating cancer. By examining how these cells interact with tumors, the study aims to uncover new strategies for enhancing cancer therapies. The approach includes analyzing the molecular mechanisms that allow these immune cells to inhibit tumor growth and improve the effectiveness of existing cancer treatments. Patients may benefit from insights that could lead to more effective immunotherapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from enhanced immunotherapy approaches.
Not a fit: Patients with non-cancerous conditions or those who are not undergoing cancer treatment may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative cancer treatments that harness the power of the immune system.
How similar studies have performed: Previous research has shown promise in utilizing immune cells for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
La Jolla, UNITED STATES
- Salk Institute for Biological Studies — La Jolla, United States (Active)
Researchers
- Principal investigator: Sakuma, Stephen — Salk Institute for Biological Studies
- Study coordinator: Sakuma, Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.